NCT05469126View on ClinicalTrials.gov

A Drug Interaction Study of Clarithromycin and LY3502970 in Healthy Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

26

Participants

Timeline

Start Date

August 1, 2022

Primary Completion Date

November 3, 2022

Study Completion Date

November 3, 2022

Conditions

Healthy

Interventions

DRUG

LY3502970

Administered orally.

DRUG

Clarithromycin

Administered orally.

Trial Locations (1)

138623

Lilly Centre for Clinical Pharmacology, Singapore

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY